Industry News
Zytiga Prednisone Combo Metastatic Castration-Resistant Prostate Cancer Trial Unblinded
Mar 10, 2012
A new statement by Janssen Research & Development, LLC informs that they have unblinded the Phase 3 study, COU-AA-302, which shows that Zytiga (abiraterone acetate), when taken alongside prednisone, is effective in treating mildly symptomatic or asymptomatic patients who are suffering from metastatic castration-resistant prostate cancer (CRPC) and have not gone through chemotherapy... Read More
Seeking Out The 'Achilles' Heel' Of Clot-Buster Plasmin
Mar 10, 2012
Everyone is familiar with the pain of skinned knees. However, the complex pathway of proteins that works behind the scenes after the bleeding has stopped is not as well known. Central to this process is the production of plasmin, a powerful blood enzyme that disposes of blood clots. Doctors also harness the "clot busting" abilities of plasmin to treat patients who suffer heart attack or stroke... Read More
Seeking Out The 'Achilles' Heel' Of Clot-Buster Plasmin
Mar 10, 2012
Everyone is familiar with the pain of skinned knees. However, the complex pathway of proteins that works behind the scenes after the bleeding has stopped is not as well known. Central to this process is the production of plasmin, a powerful blood enzyme that disposes of blood clots. Doctors also harness the "clot busting" abilities of plasmin to treat patients who suffer heart attack or stroke... Read More
Bowel Cancer - New Clinical Guidelines
Mar 09, 2012
The new clinical guidelines for the prevention, detection and management of bowel cancer have been published by the Cancer Council Australia. Dr. Cameron Bell, Chair of the Surveillance Colonoscopy Guidelines Working Party, says that the guidelines offer proven information that assists practitioners in deciding when a surveillance colonoscopy is required... Read More
Bowel Cancer - New Clinical Guidelines
Mar 09, 2012
The new clinical guidelines for the prevention, detection and management of bowel cancer have been published by the Cancer Council Australia. Dr. Cameron Bell, Chair of the Surveillance Colonoscopy Guidelines Working Party, says that the guidelines offer proven information that assists practitioners in deciding when a surveillance colonoscopy is required... Read More
First 'Theranostic' Treatment For Acute Lymphoblastic Leukemia
Mar 09, 2012
A team of researchers at Case Western Reserve University School of Medicine has developed the first "theranostic" agent for the treatment of acute lymphoblastic leukemia (ALL). ALL is the most common type of childhood cancer diagnosed in approximately 5,000 new cases each year in the United States... Read More
New Way To Study Liver Cancer Created By Wilmot Researchers
Mar 09, 2012
Researchers at the University of Rochester Medical Center's James P. Wilmot Cancer Center have made significant strides in the study of a primary cancer of the liver - Intrahepatic Cholangiocarcinoma (IHCC), also called biliary tract cancer. Their work has been published online and in print editions of Cancer Research, the most frequently cited cancer journal in the world. Aram Hezel, M.D... Read More
Research Sheds Light On Cancer Of The Appendix
Mar 09, 2012
Researchers at Wake Forest Baptist Medical Center have demonstrated that cancer of the appendix is different than colon cancer, a distinction that could lead to more effective treatments for both diseases. The study by Edward A. Levine, M.D., professor of surgery and chief of the surgical oncology service at Wake Forest Baptist, is the result of gene analysis of cases covering a 10-year period... Read More
New Study Clarifies Crystal Structure Of Archael Chromatin
Mar 09, 2012
Researchers at the RIKEN SPring-8 Center in Harima, Japan have clarified for the first time how chromatin in archaea, one of the three evolutionary branches of organisms in nature, binds to DNA... Read More
New Way To Study Liver Cancer Created By Wilmot Researchers
Mar 09, 2012
Researchers at the University of Rochester Medical Center's James P. Wilmot Cancer Center have made significant strides in the study of a primary cancer of the liver - Intrahepatic Cholangiocarcinoma (IHCC), also called biliary tract cancer. Their work has been published online and in print editions of Cancer Research, the most frequently cited cancer journal in the world. Aram Hezel, M.D... Read More
Previous Page Next Page